These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31446426)

  • 41. Management of arrhythmias in patients with Takotsubo cardiomyopathy: Is the implantation of permanent devices necessary?
    Stiermaier T; Rommel KP; Eitel C; Möller C; Graf T; Desch S; Thiele H; Eitel I
    Heart Rhythm; 2016 Oct; 13(10):1979-86. PubMed ID: 27298201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical utilisation of implantable loop recorders in adults with Fabry disease-a multi-centre snapshot study.
    Roy A; Vijapurapu R; Kurdi H; Orsborne C; Woolfson P; Kalla M; Jovanovic A; Miller CA; Moon JC; Hughes DA; Geberhiwot T; Steeds RP
    Front Cardiovasc Med; 2023; 10():1323214. PubMed ID: 38144365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2017].
    Proclemer A; Zecchin M; D'Onofrio A; Ricci RP; Boriani G; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Miconi A; Zorzin AF; Gregori D
    G Ital Cardiol (Rome); 2019 Mar; 20(3):136-148. PubMed ID: 30821295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry.
    Cikes M; Jakus N; Claggett B; Brugts JJ; Timmermans P; Pouleur AC; Rubis P; Van Craenenbroeck EM; Gaizauskas E; Grundmann S; Paolillo S; Barge-Caballero E; D'Amario D; Gkouziouta A; Planinc I; Veenis JF; Jacquet LM; Houard L; Holcman K; Gigase A; Rega F; Rucinskas K; Adamopoulos S; Agostoni P; Biocina B; Gasparovic H; Lund LH; Flammer AJ; Metra M; Milicic D; Ruschitzka F;
    Eur J Heart Fail; 2019 Sep; 21(9):1129-1141. PubMed ID: 31410955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postmortem Interrogation of Cardiac Implantable Electronic Devices: A 15-Year Experience.
    Paratz ED; Block TJ; Stub DA; La Gerche A; Kistler PM; Kalman JM; Strathmore N; Mond H; Woodford NWF; Burke M; Voskoboinik A
    JACC Clin Electrophysiol; 2022 Mar; 8(3):356-366. PubMed ID: 35331431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imaging in patients with cardiovascular implantable electronic devices: part 1-imaging before and during device implantation. A clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI) and the European Heart Rhythm Association (EHRA) of the ESC.
    Stankovic I; Voigt JU; Burri H; Muraru D; Sade LE; Haugaa KH; Lumens J; Biffi M; Dacher JN; Marsan NA; Bakelants E; Manisty C; Dweck MR; Smiseth OA; Donal E; ;
    Eur Heart J Cardiovasc Imaging; 2023 Dec; 25(1):e1-e32. PubMed ID: 37861372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
    Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
    Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular Implantable Electronic Device Surgery Following Left Ventricular Assist Device Implantation.
    Black-Maier E; Lewis RK; Loungani R; Rehorn M; Friedman DJ; Bishawi M; Schroder JN; Milano CA; Katz JN; Patel CB; Rogers JG; Hegland DD; Jackson KP; Frazier-Mills C; Pokorney SD; Daubert JP; Piccini JP
    JACC Clin Electrophysiol; 2020 Sep; 6(9):1131-1139. PubMed ID: 32972548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
    Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electromagnetic interference on cardiac pacemakers and implantable cardioverter defibrillators during endoscopy as reported to the US Federal Drug Administration.
    Samuels JM; Overbey DM; Wikiel KJ; Jones TS; Robinson TN; Jones EL
    Surg Endosc; 2021 Jul; 35(7):3796-3801. PubMed ID: 32804270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias.
    Saksena S; Prakash A; Madan N; Giorgberidze I; Munsif AN; Mathew P; Kaushik R; Krol RB
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():149-54. PubMed ID: 8734177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
    Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
    JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac implantable electronic device placement following alcohol septal ablation for hypertrophic cardiomyopathy in the United States.
    Lam MC; Naidu SS; Kolte D; Kennedy K; Feldman DN; Chu AF; Abbott JD; Gordon P; Aronow HD
    J Cardiovasc Electrophysiol; 2020 Oct; 31(10):2712-2719. PubMed ID: 32671899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.